The exosomes market in the UAE is expected to reach a projected revenue of US$ 2.1 million by 2030. A compound annual growth rate of 22.9% is expected of the UAE exosomes market from 2025 to 2030.
In terms of revenue, UAE accounted for 0.3% of the global exosomes market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, Saudi Arabia exosomes market is projected to lead the regional market in terms of revenue in 2030.
Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 4.3 million by 2030.
Rising investments by academic as well research institutes to perform exosomes-related research is expected to boost the UAE exosomes market in the coming years. For instance, New York University Abu Dhabi has a separate department fully integrated for research on solutions for complex bioengineering challenges.
The university is currently focusing on understanding the electro kinetics of microfluidic biosensors in the identification of exosomes to enhance research related to cancer and point-of-care diagnostics. Robust distribution network of exosome companies in the country is also expected to propel the market growth.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 66.67% in 2024.
Horizon Databook has segmented the Uae exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Rising investments by academic as well research institutes to perform exosomes-related research is expected to boost the UAE exosomes market in the coming years. For instance, New York University Abu Dhabi has a separate department fully integrated for research on solutions for complex bioengineering challenges.
The university is currently focusing on understanding the electro kinetics of microfluidic biosensors in the identification of exosomes to enhance research related to cancer and point-of-care diagnostics. Robust distribution network of exosome companies in the country is also expected to propel the market growth.
Uae Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Isolation Methods
Downstream Analysis
Uae Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
Kits & Reagents
Instruments
Services
Uae Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals & diagnostics centers
Pharmaceutical & biotechnology companies
Academic & research institutes
Uae Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
Neurodegenerative diseases
Cardiovascular diseases
Others
Cancer
Infectious diseases
Reasons to subscribe to Exosomes Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exosomes Market Outlook databook
Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Exosomes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.